Table 1 Tumor characteristics at baseline in patients with advanced stage IV CRC.
No. of patients n = 20 | % | |
|---|---|---|
Age (Years) | 67 (39–82) | |
Median (range) | ||
Sex | ||
Male | 14 | 70% |
Female | 6 | 30% |
Tumor origin | ||
Colon | 14 | 70% |
Rectum | 6 | 30% |
Performance status (ECOG) | ||
0 | 1 | 5% |
1 | 12 | 60% |
2 | 5 | 25% |
3 | 2 | 10% |
4 | 0 | 0% |
Sites of synchrone metastases | ||
Liver | 17 | 85% |
Lung | 11 | 55% |
Lymph nodes | 5 | 25% |
Peritoneal | 2 | 10% |
Bone | 1 | 5% |
Number of metastatic sites | ||
1 | 8 | 40% |
2 | 6 | 30% |
≥3 | 6 | 30% |